Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
Communication
Organic & Biomolecular Chemistry
The synthetic utility of the present process was demonstrated
by the late-stage functionalization of a drug molecule, the
gram-scale synthesis and the elaboration of the products.
Further investigation of this three-component tandem aryla-
tion and regioselective allylic substitution with other nucleo-
philes is currently underway in our laboratory and will be
reported in due course.
(k) T.-H. Huang, H.-M. Chang, M.-Y. Wu and C.-H. Cheng,
J. Org. Chem., 2002, 67, 99; (l) M. W. V. Laren, J. J. Diederen
and C. J. Elsevier, Adv. Synth. Catal., 2001, 343, 255;
(m) M.-Y. Wu, F.-Y. Yang and C.-H. Cheng, J. Org. Chem.,
1999, 64, 2471.
4 Pd–H-Catalyzed allylic substitution of allenes has also been
reported, see: (a) J. A. Brekan, T. E. Reynolds and
K. A. Scheidt, J. Am. Chem. Soc., 2010, 132, 1472;
(b) A. Deagostino, C. Prandi, A. Toppino and P. Venturello,
Tetrahedron, 2008, 64, 10344; (c) S. Brown, R. Grigg,
J. Hinsley, S. Korn, V. Sridharan and M. D. Uttley,
Tetrahedron, 2001, 57, 10347; (d) M. Al-Masum, M. Meguro
and Y. Yamamoto, Tetrahedron Lett., 1997, 38, 6071;
(e) L. Besson, J. Goré and B. Cazes, Tetrahedron Lett., 1995,
36, 3857; (f) Y. Yamamoto, M. Al-Masum and N. Asao,
J. Am. Chem. Soc., 1994, 116, 6019; (g) I. Shimizu, T. Sugiura
and J. Tsuji, J. Org. Chem., 1985, 50, 537.
5 S. Ma and S. Zhao, J. Am. Chem. Soc., 2001, 123, 5578.
6 For selected reviews, see: (a) Z. Lu and S. Ma, Angew.
Chem., Int. Ed., 2008, 47, 258; (b) B. M. Trost and
M. L. Crawley, Chem. Rev., 2003, 103, 2921.
7 (a) H. Xu, S. Khan, H. Li, X. Wu and Y. J. Zhang, Org. Lett.,
2019, 21, 214; (b) I. Khan, H. Li, X. Wu and Y. J. Zhang,
Acta Chim. Sin., 2018, 76, 874; (c) J.-N. Xie, W.-S. Guo,
A.-J. Cai, E. C. Escudero-Adán and A. W. Kleij, Org. Lett.,
2017, 19, 6388; (d) A. Khan, R. Zheng, Y. Kan, J. Ye, J. Xing
and Y. J. Zhang, Angew. Chem., Int. Ed., 2014, 53, 6439.
8 A. Khan, S. Khan, I. Khan, C. Zhao, Y. Mao, Y. Chen and
Y. J. Zhang, J. Am. Chem. Soc., 2017, 139, 10733.
Conflicts of interest
There are no conflicts to declare.
Acknowledgements
This work was supported by the National Natural Science
Foundation of China (21572130 and 21871179), the Innovation
Fund from the Joint Research Center for Precision Medicine
set up by Shanghai Jiao Tong University and Affiliated Sixth
People’s Hospital South Campus (IFPM2017B008). We thank
the Instrumental Analysis Center of Shanghai Jiao Tong
University for HRMS analysis.
Notes and references
1 For selected reviews, see: (a) V. Farina, Adv. Synth. Catal.,
2004, 346, 1553; (b) I. P. Beletskaya and A. V. Cheprakov,
Chem. Rev., 2000, 100, 3009; (c) A. De Meijere and
F. E. Meyer, Angew. Chem., Int. Ed. Engl., 1994, 33, 2379;
(d) R. F. Heck, Acc. Chem. Res., 1979, 12, 146.
9 Pd-Catalyzed tandem arylation and allylic cycloaddition of
2,3-allenol with aryl iodides and unsaturated electrophiles
have also been reported, see: (a) Y. Hou, M. Qin, X. Yang,
Q. Shen, Y. Zhao, Y. Liu and P. Gong, RSC Adv., 2017, 7, 7401;
(b) K. Uemura, D. Shiraishi, M. Noziri and Y. Inoue, Bull.
Chem. Soc. Jpn., 1999, 72, 1063; (c) R. D. Walkup, L. Guan,
Y. S. Kim and S. W. Kim, Tetrahedron Lett., 1995, 36, 3805.
2 I. Shimizu and J. Tsuji, Chem. Lett., 1984, 13, 233.
3 For selected examples for the Pd-catalyzed tandem aryla-
tion and allylic substitution of allenes, see: (a) Y. Hou,
Q. Shen, Z. Li, S. Chen, Y. Zhao, M. Qin and P. Gong, Adv.
Synth. Catal., 2018, 360, 631; (b) G. Hu, J. Wang, Z. Li,
Y. Liu and P. Gong, New J. Chem., 2018, 42, 1736; 10 For the regioselective allylic etherification via Pd/B dual cat-
(c) X.-X. Wu, C. Wang, W. Zhao, H. Zhao and S. Chen,
Synthesis, 2018, 50, 4097; (d) J. Yang, H. Mo, X. Jin, D. Cao,
H. Wu, D. Chen and Z. J. Wang, Org. Chem., 2018, 83, 2592;
(e) Y. Tang, Q. Yu and S. Ma, Org. Chem. Front., 2017, 4,
alysis, also see: (a) B. M. Trost, E. J. McEachern and
F. D. Toste, J. Am. Chem. Soc., 1998, 120, 12702;
(b) B. M. Trost, B. S. Brown, E. J. McEachern and O. Kuhn,
Chem. – Eur. J., 2003, 9, 4442.
1762; (f) Y. Hou, Q. Shen, L. Zhu, Y. Han, Y. Zhao, M. Qin 11 When triethylborane is used, BEt3 likely reacts with ROH to
and P. Gong, RSC Adv., 2017, 7, 50372; (g) M.-G. Braun,
M. H. Katcher and A. G. Doyle, Chem. Sci., 2013, 4, 1216;
(h) S. Husinec, M. Petkovic, V. Savic and M. Simic,
generate B(OR)Et2 and B(OR)2Et, so the real boron-co-cata-
lyst should be a mixture of B(OR)Et2, B(OR)2Et, or B(OR)3
in some cases. See ref. 8.
Synthesis, 2012, 44, 399; (i) M. Aylward, V. Coeffard and 12 (a) P. Howard, R. Twycross, J. Shuster, M. Mihalyo and
P. J. Guiry, J. Org. Chem., 2011, 76, 3536; ( j) S. Husinec,
M. Jadranin, R. Markovic, M. Petkovic, V. Savic and
N. Todorovic, Tetrahedron Lett., 2010, 51, 4066;
A. Wilcock, J. Pain Symptom Manage., 2011, 41, 956;
(b) M. J. Ohlow and B. Moosmann, Drug Discovery Today,
2011, 16, 119.
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2019